切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2018, Vol. 15 ›› Issue (09) : 673 -678. doi: 10.3877/cma.j.issn.1672-6448.2018.09.007

所属专题: 文献

外周血管超声影像学

超声评估锁骨下动脉支架植入术后残余狭窄的影响因素
李秋萍1, 华扬1,(), 王力力1, 贾凌云1, 雷娜1, 唐煜1   
  1. 1. 100053 北京,首都医科大学宣武医院血管超声诊断科
  • 收稿日期:2018-07-04 出版日期:2018-09-01
  • 通信作者: 华扬

Evaluation of the influencing factors of residual stenosis after subclavian artery stent placement by ultrasonography

Qiuping Li1, Yang Hua1,(), Lili Wang1, Lingyun Jia1, Na Lei1, Yu Tang1   

  1. 1. Department of Vascular Ultrasonagraphy, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
  • Received:2018-07-04 Published:2018-09-01
  • Corresponding author: Yang Hua
  • About author:
    Corresponding author: Hua Yang, Emial:
引用本文:

李秋萍, 华扬, 王力力, 贾凌云, 雷娜, 唐煜. 超声评估锁骨下动脉支架植入术后残余狭窄的影响因素[J/OL]. 中华医学超声杂志(电子版), 2018, 15(09): 673-678.

Qiuping Li, Yang Hua, Lili Wang, Lingyun Jia, Na Lei, Yu Tang. Evaluation of the influencing factors of residual stenosis after subclavian artery stent placement by ultrasonography[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2018, 15(09): 673-678.

目的

探讨超声评估锁骨下动脉支架(SAS)植入术后残余狭窄的发生率及其相关影响因素。

方法

回顾性纳入2015年5月至2018年4月于首都医科大学宣武医院行SAS植入术的锁骨下动脉重度狭窄(狭窄率≥70%)或闭塞患者,共201例(204枚支架)。所有患者均于术前和术后1个月内行彩色多普勒血流成像(CDFI)检查。数字减影血管造影(DSA)和CDFI显示SAS后狭窄率≥20%定义为残余狭窄。分析锁骨下动脉狭窄与闭塞病变特征、支架类型与长度等对SAS残余狭窄发生率的影响。

结果

本组204枚支架中有67枚(32.8%)发生SAS≥20%残余狭窄;其中有2枚SAS残余狭窄为≥50%。残余狭窄组与无残余狭窄组患者年龄、性别、动脉硬化危险因素如糖尿病、高血脂、冠心病、吸烟等差异均无统计学意义,但是残余狭窄组高血压患者比例高于无残余狭窄组[68.7%(46/67) vs 48.5%(65/134)],且差异有统计学意义(P=0.007)。残余狭窄组斑块钙化面积≥1/2者所占比例、自膨式支架所占比例、支架原始长度均高于或大于无残余狭窄组[34.3%(23/67) vs 9.5%(13/137),28.4%(19/67) vs 4.4%(6/137),(26.7±7.7)mm vs (23.8±6.3)mm],且差异均有统计学意义(χ2=19.103,P<0.001;χ2=24.059,P<0.001;t=2.601,P=0.011);残余狭窄组术前SA闭塞者所占比例高于无残余狭窄组,但差异无统计学意义;而两组SA病变长度、病变原始内径、支架原始内径差异无统计学意义。经多因素Logistic回归分析结果显示,斑块钙化程度、支架类型(OR=7.205,95%CI:3.175~16.348,P=0.000;OR=8.591,95%CI:2.825~26.131,P=0.000)均是SAS术后残余狭窄的独立危险因素。

结论

超声能够准确评价SAS的效果,及时发现残余狭窄,术前斑块钙化面积和支架类型是影响SAS术后残余狭窄的主要因素。

Objective

To investigate the incidence of residual stenosis and its influencing factors after subclavian artery stent placement using color Doppler flow imaging (CDFI).

Methods

A total of 201 consecutive patients (204 stents) with severe subclavian artery stenosis (≥70%) or occlusion who underwent subclavian artery stent (SAS) in our hospital from May 2015 to April 2018 were enrolled. All patients were examined by CDFI within one month before and after surgery. According to the results of digital subtraction angiography (DSA) and CDFI detected, the stenosis≥20% after the SAS is defined as in-stent residual stenosis (ISRS). All of 204 stents were divided into ISRS group (67, 32.8%) and non ISRS group (137, 67.2%). The characteristics of SA, type and length of stent were analyzed and compared.

Results

The both groups had no significant differences in age, gender, atherosclerosis risk factors such as diabetes, hyperlipidemia, coronary heart disease, smoking, etc. (P>0.05), but the proportion of hypertension in the ISRS group was higher relatively (68.7% and 48.5%, P=0.007). The area of intra-plaque calcification ≥1/2 was also much more larger than that in non-ISRS group (34.3% vs 9.5%) (P=0.000). There was no significant difference between the length of stenosis and the original diameter of the lesion (P>0.05). The type of stent in ISRS group was mainly self-expanding stent (P=0.000), and the original length of stent was longer than that in non-ISRS group (P=0.011), while the original inner diameter of the stent was no significant difference between the two groups (P=0.454). Multivariate Logistic regression analysis showed that the degree of the plaque calcification (OR=7.205, 95%CI: 3.175-16.348, P=0.000), and stent type (OR=8.591, 95%CI: 2.825-26.131, P=0.000) were independent risk factors for residual stenosis after SAS.

Conclusions

Ultrasound can accurately evaluate the effect of subclavian artery stent placement, detect residual stenosis in time. Preoperative calcification area and stent type are the main factors affecting residual stenosis.

表1 SAS植入术后残余狭窄组与无残余狭窄组患者一般临床资料比较
图6 术后数字减影血管造影示右侧锁骨下动脉内置入球扩支架9-18,存在残余狭窄
表2 SAS植入术后残余狭窄组与无残余狭窄组支架内径及血流动力学参数比较(±s
表3 SAS植入术后残余狭窄组与无残余狭窄组残余狭窄影响因素比较
表4 SAS植入术后残余狭窄影响因素的多因素Logistic回归分析结果
1
Fields WS,Lemak NA. Joint Study of Extracranial Arterial Occlusion Ⅷ. Subclavian Steal--A Review of 168 Cases [J]. JAMA, 1972, 222(9): 1139-1143.
2
AbuRahma AF,Bates MC,Stone PA, et al. Angioplasty and stenting versus carotid-subclavian bypass for the treatment of isolated subclavian artery disease [J]. Endovasc Ther, 2007, 14(5): 698-704.
3
Shah PK. Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken [J]. Circulation, 2003, 107(17): 2175-2177.
4
Song L,Zhang J,Li J, et al. Endovascular stenting vs. extrathoracic surgical bypass for symptomatic subclavian steal syndrome [J]. J Endovasc Ther, 2012, 19(1): 44-51.
5
Przewlocki T,Kablak-Ziembicka A,Pieniazek P, et al. Determinants of immediate and long-term results of subclavian and innominate artery angioplasty [J]. Catheter Cardiovasc Interv, 2006, 67(4): 519-526.
6
华扬,李景植,贾凌云, 等. 超声检测椎动脉支架置入后再狭窄及其影响因素的分析 [J]. 中国脑血管病杂志, 2012, 9(11): 569-572.
7
国家卫生计生委脑卒中防治工程委员会. 中国脑卒中血管超声检查指导规范 [J/CD]. 中华医学超声杂志(电子版), 2015, 12(8): 599-610.
8
Samuels OB,Joseph GJ,Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis [J]. AJNR Am J Neuroradiol, 2000, 21(4): 643-646.
9
Bachman DM,Kim RM.Transluminal dilatation for subclavian steal syndrome [J]. AJR Am J Roentgenol, 1980, 135(5): 995-996.
10
Ahmed AT,Mohammed K,Chehab M, et al. Comparing Percutaneous Transluminal Angioplasty and Stent Placement for Treatment of Subclavian Arterial Occlusive Disease: A Systematic Review and Meta-Analysis [J]. Cardiovasc Intervent Radiol, 2016, 39(5): 652-667.
11
陶昀璐,华扬,贾凌云, 等. 颈动脉狭窄血管结构特征与支架术后残余狭窄的相关性分析 [J]. 中华超声影像学杂志, 2017, 26(6): 490-493.
12
Polak JF,Meisner A,Pencina MJ, et al. Variations in common carotid artery intima-media thickness during the cardiac cycle: implications for cardiovascular risk assessment [J]. J Am Soc Echocardiogr, 2012, 25(9): 1023-1028.
13
华扬,唐旸烁,段春, 等. 应用超声评估颈动脉支架置入后残余狭窄的影响因素 [J]. 中国脑血管杂志, 2012, 9(11): 573-576, 589.
14
Brott TG,Halperin JL,Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on nial carotid and vertebral artery disease: executivesummary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery [J]. J Am Coll Cardiol, 2011, 57(8): 1002-1044.
15
Mintz GS,Popma JJ,Piehard AD, et al. Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions [J]. Circulation, 1995, 91(7): 1959-1965.
16
Katano H,Mase M,Nishikawa Y, et al. Surgical treatment for carotid stenoses with highly calcified plaques [J]. J Stroke Cerebrovasc Dis, 2014, 23(1): 148-154.
17
Coppi G,Moratto R,Veronesi J, et al. Carotid artery stent fracture identification and clinical relevance [J]. J Vasc Surg, 2010, 51(6): 1397-1405.
18
Henkes H,Miloslavski E,Lowens S, et al. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan) [J]. Neuroradiology, 2005, 47(3): 222.
19
Miyakoshi A,Hatano T,Tsukahara T, et al. Percutaneous transluminal angioplasty for atherosclerotic stenosis of the subclavian or innominate artery: angiographic and clinical outcomes in 36 patients [J]. Neurosurg Rev, 2012, 35(1): 121-125.
20
Babic S,Sagic D,Radak D, et al. Initial and long-term results of endovascular therapy for chronic total occlusion of the subclavian artery [J]. Cardiovasc Intervent Radiol, 2012, 35(2): 255-262.
21
Zhang JL,Tong W,Lv JF, et al. Endovascular treatment and morphology typing of chronic ostial occlusion of the subclavian artery [J]. Exp Ther Med, 2017, 13(5): 2022-2028.
[1] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[2] 麻紫月, 王贞文, 张强, 赵代伟, 张翊伦. 右侧喉不返神经1例报告[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 115-116.
[3] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[4] 中华医学会器官移植学分会. 中国肺移植气道并发症临床诊疗指南(2024版)[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 266-274.
[5] 李佳伟, 庞建智, 闫鹏宇, 卫阳兵, 杨晓峰. 术中输尿管识别技术研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 520-524.
[6] 晏爽, 姜华, 陈键, 潘蕾, 金发光. 支气管结石临床特征及预后分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 595-599.
[7] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[8] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[9] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[10] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[11] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[12] 孙明策, 韩世焕. 海藻酸盐水凝胶支架在颅骨缺损修复中的应用进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 310-314.
[13] 邵佳申, 张志武, 孟海, 杨雍, 费琦. 单侧双通道脊柱内镜技术治疗腰椎管狭窄症的临床疗效和学习曲线研究[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(04): 202-208.
[14] 牟磊, 徐东成, 韩鑫, 徐长江, 韩坤锜, 薛叶潇, 牟媛, 秦文玲, 刘相静, 陈哲, 高楠. 五虫通络胶囊防治椎动脉开口支架术后再狭窄发生的效果[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 467-472.
[15] 刘焕亮, 崔慧娟, 曹慧, 付源. 颈动脉狭窄处剪切率对高同型半胱氨酸血症患者脑梗死的预测价值[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 317-322.
阅读次数
全文


摘要